Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies

Project Information

COMbAT

Grant agreement ID: 677645

DOI

10.3030/677645

Project closed

EC signature date 10 September 2015

Start date 1 October 2015

End date 31 March 2017

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 150 000,00

EU contribution

€ 150 000,00

Coordinated by

WEIZMANN INSTITUTE OF SCIENCE
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Recurrent inactivating RASA2 mutations in melanoma

Author(s): Rand Arafeh, Nouar Qutob, Rafi Emmanuel, Alona Keren-Paz, Jason Madore, Abdel Elkahloun, James S Wilmott, Jared J Gartner, Antonella Di Pizio, Sabina Winograd-Katz, Sivasish Sindiri, Ron Rotkopf, Ken Dutton-Regester, Peter Johansson, Antonia L Pritchard, Nicola Waddell, Victoria K Hill, Jimmy C Lin, Yael Hevroni, Steven A Rosenberg, Javed Khan, Shifra Ben-Dor, Masha Y Niv, Igor Ulitsky, Graham J M
Published in: Nature Genetics, Issue 47/12, 2015, Page(s) 1408-1410, ISSN 1061-4036
Publisher: Nature Publishing Group
DOI: 10.1038/ng.3427

Intellectual Property Rights

Other (1)

VECTORS, COMPOSITIONS AND METHODS FOR ENDOGENOUS EPTOPE TAGGING OF TARGET GENES FIELD OF THE INVENTION

Application/Publication number: PCT IL2016/050035
Date: 2016-07-21
Applicant(s): WEIZMANN INSTITUTE OF SCIENCE